John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$332M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$309M |
| 3 |
Nike
NKE
|
+$252M |
| 4 |
NVIDIA
NVDA
|
+$209M |
| 5 |
Target
TGT
|
+$202M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$238M |
| 2 |
PCGU
PG&E Corporation
PCGU
|
+$218M |
| 3 |
ConocoPhillips
COP
|
+$185M |
| 4 |
Amazon
AMZN
|
+$165M |
| 5 |
Cigna
CI
|
+$159M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.77% |
| 2 | Healthcare | 13.86% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Industrials | 11.24% |
| 5 | Financials | 9.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Weyerhaeuser
WY
$17.5B
| $8.52M | 0.02% |
+254,269
| New | +$7.65M |
|
677
Lumentum
LITE
$74.7B
| $8.49M | 0.02% |
149,702
-419,807
| -74% | -$21M |
|
678
Clear Secure
YOU
$4.6B
| $8.43M | 0.02% |
363,672
-91,093
| -20% | -$2.25M |
|
679
Fair Isaac
FICO
$25.1B
| $8.38M | 0.02% |
10,358
+7,495
| +262% | +$5.62M |
|
680
Oaktree Specialty Lending
OCSL
$1.15B
| $8.38M | 0.02% |
431,207
+20,973
| +5% | +$394K |
|
681
10x Genomics
TXG
$8.23B
| $8.37M | 0.02% |
149,887
+124,787
| +497% | +$6.75M |
|
682
Molina Healthcare
MOH
$10.4B
| $8.31M | 0.02% |
27,601
-84,443
| -75% | -$24.3M |
|
683
GlobalFoundries
GFS
$25.3B
| $8.27M | 0.02% |
128,033
+118,018
| +1,178% | +$7.14M |
|
684
Sixth Street Specialty
TSLX
$1.8B
| $8.26M | 0.02% |
441,811
+276,729
| +168% | +$5.04M |
|
685
Huron Consulting
HURN
$2.58B
| $8.25M | 0.02% |
97,192
+8,075
| +9% | +$662K |
|
686
Akamai
AKAM
$15.3B
| $8.22M | 0.02% |
91,451
-520,086
| -85% | -$44.6M |
|
687
Lantheus
LNTH
$6.56B
| $8.2M | 0.02% |
97,732
-4,485
| -4% | -$402K |
|
688
Lennox International
LII
$13.7B
| $8.18M | 0.02% |
25,086
-11,578
| -32% | -$3.27M |
|
689
FS KKR Capital
FSK
$3.3B
| $8.15M | 0.02% |
424,770
+103,958
| +32% | +$1.97M |
|
|
CMA
690
DELISTED
Comerica
CMA
| $8.13M | 0.02% |
191,986
+187,200
| +3,911% | +$7.57M |
|
691
Editas Medicine
EDIT
$470M
| $8.12M | 0.02% |
986,420
+277,511
| +39% | +$2.42M |
|
692
Repligen
RGEN
$10.2B
| $8.11M | 0.02% |
+57,317
| New | +$9.19M |
|
|
SILK
693
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $8.09M | 0.02% |
248,873
-34,903
| -12% | -$1.27M |
|
|
QVCGA
694
DELISTED
QVC Group Inc Series A
QVCGA
| $8.09M | 0.02% |
163,367
+10,328
| +7% | +$465K |
|
695
Impinj
PI
$4.85B
| $8.08M | 0.02% |
90,148
-274,851
| -75% | -$29.3M |
|
|
HAPN
696
Happen Inc
HAPN
$2.12B
| $8.06M | 0.02% |
826,851
-324,529
| -28% | -$2.61M |
|
697
Hess Midstream
HESM
$5B
| $8.05M | 0.02% |
262,444
+171,680
| +189% | +$4.95M |
|
698
Legend Biotech
LEGN
$4.08B
| $8.02M | 0.02% |
+116,223
| New | +$7.59M |
|
699
Hayward Holdings
HAYW
$3.07B
| $8.02M | 0.02% |
624,244
-184,019
| -23% | -$2.12M |
|
700
Ezcorp Inc
EZPW
$2.1B
| $8.01M | 0.02% |
955,911
+267,876
| +39% | +$2.32M |
|
Similar funds
John Overdeck's Q2 2023 Portfolio in Review
As of Q2 2023, John Overdeck held 3,452 positions worth $39.9B, up 14% from $35B the previous quarter. Its ten largest holdings account for 7.6% of the portfolio.
John Overdeck deployed $2.46B of net new capital in Q2 2023, opening 521 new positions and adding to 1,149 existing holdings. Its largest new stake was Nike: 2,150,643 shares worth $237M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 12% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Netflix, an estimated $238M trimmed.
- John Overdeck's largest Q2 2023 buy was Nike: 2,150,643 shares worth $237M.
- John Overdeck added most to State Street SPDR S&P 500 ETF Trust in Q2 2023, an estimated $332M increase.
- John Overdeck's biggest Q2 2023 reduction was Netflix, cutting an estimated $238M.
- John Overdeck fully exited Goldman Sachs in Q2 2023, selling an estimated $127M.
- John Overdeck's ten largest holdings make up 7.6% of its $39.9B portfolio in Q2 2023.
- John Overdeck opened 521 new positions and closed 479 in Q2 2023.
- John Overdeck's portfolio value rose 14% quarter-over-quarter to $39.9B.
Based on Two Sigma Investments's 13F filing for Q2 2023, filed 14 Aug 2023.